Patents Assigned to Erasca, Inc.
  • Tricyclic pyridones and pyrimidones
    Patent number: 11845761
    Abstract: Compounds with KRAS G12C inhibitory active are disclosed and methods of using the same to treat a cancer comprising a K-Ras G12C mutation.
    Type: Grant
    Filed: December 8, 2022
    Date of Patent: December 19, 2023
    Assignee: Erasca, Inc.
    Inventors: Jun Feng, Jean-Michel Vernier, Marcos Gonzalez-Lopez, Benjamin Jones, Nicholas A. Isley, Ping Chen